James L Tyree Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James L Tyree.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James L Tyree. James L Tyree is Executive Vice President in ABBOTT LABORATORIES ($ABT) and Senior Vice President in ABBOTT LABORATORIES ($ABT) and Director in DEPOMED INC ($DMI) and Director in Innoviva, Inc. ($THRX) and Director in ChemoCentryx, Inc. ($CCXI) and Director in Assertio Holdings, Inc. ($ASRT).
Latest Insider Trading Transactions of James L Tyree
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, ASRT, DMI, CCXI, THRX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | ASRT | Assertio Holdings, ... | Tyree James L | Director | Grant | A | 0.00 | 357,143 | 0 | 675,233 | 318.1 K to 675.2 K (+112.28 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 7,724 | 0 | 0 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 4,660 | 0 | 4,660 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 59.73 | 2,888 | 172,500 | 2,888 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 7,724 | 0 | 13,069 | 5.3 K to 13.1 K (+144.51 %) |
May 21 2020 | ASRT | Assertio Holdings, ... | Tyree James L | Director | Grant | A | 0.00 | 237,500 | 0 | 318,090 | 80.6 K to 318.1 K (+294.70 %) |
May 21 2020 | ASRT | Assertio Holdings, ... | Tyree James L | Director | Grant | A | 0.00 | 237,500 | 0 | 318,090 | 80.6 K to 318.1 K (+294.70 %) |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 37.44 | 14,715 | 550,916 | 5,345 | 20.1 K to 5.3 K (-73.35 %) |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 36.69 | 15,285 | 560,770 | 20,060 | 35.3 K to 20.1 K (-43.25 %) |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 11.60 | 12,287 | 142,529 | 12,287 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 7,724 | 0 | 7,724 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 8,421 | 0 | 0 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 8,421 | 0 | 35,345 | 26.9 K to 35.3 K (+31.28 %) |
May 09 2019 | DMI | Assertio Therapeut ... | Tyree James L | Director | Option Exercise | M | 0.00 | 31,250 | 0 | 0 | |
May 09 2019 | DMI | Assertio Therapeut ... | Tyree James L | Director | Buy | M | 0.00 | 31,250 | 0 | 80,590 | 49.3 K to 80.6 K (+63.34 %) |
May 09 2019 | DMI | Assertio Therapeut ... | Tyree James L | Director | Grant | A | 0.00 | 39,584 | 0 | 49,340 | 9.8 K to 49.3 K (+405.74 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 12.94 | 13,352 | 172,775 | 13,352 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 8,421 | 0 | 8,421 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 12.94 | 13,352 | 172,775 | 13,352 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 8,421 | 0 | 8,421 | |
May 10 2018 | DMI | DEPOMED INC | Tyree James L | Director | Option Exercise | A | 0.00 | 31,250 | 0 | 31,250 | |
Aug 16 2017 | DMI | DEPOMED INC | Tyree James L | Director | Option Exercise | A | 0.00 | 19,512 | 0 | 19,512 | |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 20,362 | 0 | 0 | |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 20,362 | 0 | 53,849 | 33.5 K to 53.8 K (+60.81 %) |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Grant | A | 0.00 | 12,912 | 0 | 33,487 | 20.6 K to 33.5 K (+62.76 %) |
Oct 19 2016 | DMI | DEPOMED INC | Tyree James L | Director | Option Exercise | A | 23.83 | 18,485 | 440,498 | 18,485 | |
May 27 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 20,362 | 0 | 20,362 | |
May 24 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 11,795 | 0 | 0 | |
May 24 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 4.39 | 5,544 | 24,337 | 20,575 | 26.1 K to 20.6 K (-21.23 %) |
May 24 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 11,795 | 0 | 26,119 | 14.3 K to 26.1 K (+82.34 %) |
May 20 2016 | THRX | Innoviva, Inc. | Tyree James L | Director | Sell | S | 10.47 | 813 | 8,512 | 50,697 | 51.5 K to 50.7 K (-1.58 %) |
Apr 27 2016 | THRX | Innoviva, Inc. | Tyree James L | Director | Grant | A | 0.00 | 18,328 | 0 | 53,948 | 35.6 K to 53.9 K (+51.45 %) |
Jun 04 2015 | THRX | Innoviva, Inc. | Tyree James L | Director | Sell | S | 16.85 | 2,438 | 41,080 | 33,182 | 35.6 K to 33.2 K (-6.84 %) |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 27,027 | 0 | 0 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 11,795 | 0 | 11,795 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 7.45 | 12,703 | 94,593 | 14,324 | 27 K to 14.3 K (-47.00 %) |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 27,027 | 0 | 27,027 | 0 to 27 K |
Apr 27 2015 | THRX | Innoviva, Inc. | Tyree James L | Director | Grant | A | 0.00 | 13,950 | 0 | 35,620 | 21.7 K to 35.6 K (+64.37 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 47.72 | 500 | 23,860 | 132,176 | 132.7 K to 132.2 K (-0.38 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 47.71 | 700 | 33,397 | 132,676 | 133.4 K to 132.7 K (-0.52 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 47.70 | 200 | 9,540 | 133,376 | 133.6 K to 133.4 K (-0.15 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 47.70 | 300 | 14,310 | 133,576 | 133.9 K to 133.6 K (-0.22 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 47.69 | 1,500 | 71,535 | 133,876 | 135.4 K to 133.9 K (-1.11 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 47.69 | 200 | 9,537 | 135,376 | 135.6 K to 135.4 K (-0.15 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 47.68 | 200 | 9,536 | 135,576 | 135.8 K to 135.6 K (-0.15 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 47.68 | 1,300 | 61,984 | 135,776 | 137.1 K to 135.8 K (-0.95 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 47.67 | 5,554 | 264,759 | 137,076 | 142.6 K to 137.1 K (-3.89 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 50.58 | 6,813 | 344,602 | 142,630 | 149.4 K to 142.6 K (-4.56 %) |
Feb 24 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | A | 54.14 | 64,900 | 3,513,686 | 64,900 | |
Feb 24 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Grant | A | 0.00 | 45,800 | 0 | 149,443 | 103.6 K to 149.4 K (+44.19 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.09 | 4,661 | 252,123 | 103,643 | 108.3 K to 103.6 K (-4.30 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.10 | 904 | 48,907 | 108,304 | 109.2 K to 108.3 K (-0.83 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 54.94 | 3,268 | 179,544 | 109,208 | 112.5 K to 109.2 K (-2.91 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | M | 46.34 | 32,642 | 1,512,630 | 2,158 | |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | M | 54.54 | 10,856 | 592,086 | 0 | |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | M | 44.16 | 55,333 | 2,443,505 | 27,667 | |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.74 | 55,333 | 3,028,879 | 57,143 | 112.5 K to 57.1 K (-49.20 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Buy | M | 46.34 | 32,642 | 1,512,630 | 112,476 | 79.8 K to 112.5 K (+40.89 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Buy | M | 54.54 | 10,856 | 592,086 | 79,834 | 69 K to 79.8 K (+15.74 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Buy | M | 44.16 | 55,333 | 2,443,505 | 68,978 | 13.6 K to 69 K (+405.52 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.34 | 1,500 | 83,010 | 13,645 | 15.1 K to 13.6 K (-9.90 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.33 | 5,300 | 293,249 | 15,145 | 20.4 K to 15.1 K (-25.92 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.32 | 1,642 | 90,835 | 20,445 | 22.1 K to 20.4 K (-7.43 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.30 | 1,000 | 55,300 | 22,087 | 23.1 K to 22.1 K (-4.33 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.29 | 3,000 | 165,870 | 23,087 | 26.1 K to 23.1 K (-11.50 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.28 | 3,100 | 171,368 | 26,087 | 29.2 K to 26.1 K (-10.62 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.27 | 1,200 | 66,324 | 29,187 | 30.4 K to 29.2 K (-3.95 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.26 | 1,500 | 82,890 | 30,387 | 31.9 K to 30.4 K (-4.70 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.25 | 1,400 | 77,350 | 31,887 | 33.3 K to 31.9 K (-4.21 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.24 | 500 | 27,620 | 33,287 | 33.8 K to 33.3 K (-1.48 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.23 | 2,400 | 132,552 | 33,787 | 36.2 K to 33.8 K (-6.63 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.22 | 4,300 | 237,446 | 36,187 | 40.5 K to 36.2 K (-10.62 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.21 | 4,800 | 265,008 | 40,487 | 45.3 K to 40.5 K (-10.60 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 55.20 | 1,000 | 55,200 | 45,287 | 46.3 K to 45.3 K (-2.16 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.88 | 1,000 | 54,880 | 46,287 | 47.3 K to 46.3 K (-2.11 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.87 | 1,000 | 54,870 | 47,287 | 48.3 K to 47.3 K (-2.07 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.86 | 200 | 10,972 | 48,287 | 48.5 K to 48.3 K (-0.41 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.85 | 900 | 49,365 | 48,487 | 49.4 K to 48.5 K (-1.82 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.84 | 3,200 | 175,488 | 49,387 | 52.6 K to 49.4 K (-6.09 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.83 | 2,800 | 153,524 | 52,587 | 55.4 K to 52.6 K (-5.06 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.82 | 13,856 | 759,586 | 55,387 | 69.2 K to 55.4 K (-20.01 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.81 | 1,700 | 93,177 | 69,243 | 70.9 K to 69.2 K (-2.40 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.80 | 3,200 | 175,360 | 70,943 | 74.1 K to 70.9 K (-4.32 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.79 | 1,300 | 71,227 | 74,143 | 75.4 K to 74.1 K (-1.72 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.78 | 2,300 | 125,994 | 75,443 | 77.7 K to 75.4 K (-2.96 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.77 | 2,900 | 158,833 | 77,743 | 80.6 K to 77.7 K (-3.60 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.76 | 2,000 | 109,520 | 80,643 | 82.6 K to 80.6 K (-2.42 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.75 | 4,100 | 224,475 | 82,643 | 86.7 K to 82.6 K (-4.73 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.74 | 8,300 | 454,342 | 86,743 | 95 K to 86.7 K (-8.73 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.73 | 5,600 | 306,488 | 95,043 | 100.6 K to 95 K (-5.56 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.72 | 2,200 | 120,384 | 100,643 | 102.8 K to 100.6 K (-2.14 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.71 | 1,300 | 71,123 | 102,843 | 104.1 K to 102.8 K (-1.25 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.69 | 200 | 10,938 | 104,143 | 104.3 K to 104.1 K (-0.19 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.68 | 3,100 | 169,508 | 104,343 | 107.4 K to 104.3 K (-2.89 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.67 | 2,300 | 125,741 | 107,443 | 109.7 K to 107.4 K (-2.10 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.66 | 900 | 49,194 | 109,743 | 110.6 K to 109.7 K (-0.81 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.65 | 600 | 32,790 | 110,643 | 111.2 K to 110.6 K (-0.54 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.64 | 800 | 43,712 | 111,243 | 112 K to 111.2 K (-0.71 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.63 | 2,300 | 125,649 | 112,043 | 114.3 K to 112 K (-2.01 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.62 | 1,300 | 71,006 | 114,343 | 115.6 K to 114.3 K (-1.12 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.61 | 3,200 | 174,752 | 115,643 | 118.8 K to 115.6 K (-2.69 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.60 | 800 | 43,680 | 118,843 | 119.6 K to 118.8 K (-0.67 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.59 | 1,533 | 83,686 | 119,643 | 121.2 K to 119.6 K (-1.27 %) |
Feb 04 2009 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 54.58 | 200 | 10,916 | 121,176 | 121.4 K to 121.2 K (-0.16 %) |
Nov 18 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | A | 57.14 | 911 | 52,055 | 911 | |
Nov 18 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | M | 45.45 | 1,040 | 47,267 | 1,803 | |
Nov 18 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 57.14 | 911 | 52,055 | 121,376 | 122.3 K to 121.4 K (-0.74 %) |
Nov 18 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Buy | M | 45.45 | 1,040 | 47,267 | 122,287 | 121.2 K to 122.3 K (+0.86 %) |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | A | 57.76 | 4,145 | 239,415 | 4,145 | |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | M | 45.45 | 4,759 | 216,291 | 2,843 | |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 57.57 | 711 | 40,932 | 121,247 | 122 K to 121.2 K (-0.58 %) |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 57.76 | 4,145 | 239,415 | 121,958 | 126.1 K to 122 K (-3.29 %) |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Buy | M | 45.45 | 4,759 | 216,291 | 126,103 | 121.3 K to 126.1 K (+3.92 %) |
Jul 11 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | A | 57.37 | 13,171 | 755,620 | 13,171 | |
Jul 11 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | M | 45.45 | 2,200 | 99,987 | 0 | |
Jul 11 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | M | 45.45 | 13,074 | 594,198 | 7,602 | |
Jul 11 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 57.37 | 13,171 | 755,620 | 121,344 | 134.5 K to 121.3 K (-9.79 %) |
Jul 11 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Buy | M | 45.45 | 15,274 | 694,185 | 134,515 | 119.2 K to 134.5 K (+12.81 %) |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | A | 54.40 | 11,725 | 637,840 | 11,725 | |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | M | 42.83 | 10,697 | 458,153 | 0 | |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | M | 41.95 | 2,792 | 117,124 | 0 | |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 54.40 | 11,725 | 637,840 | 119,241 | 131 K to 119.2 K (-8.95 %) |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Buy | M | 42.83 | 10,697 | 458,153 | 130,966 | 120.3 K to 131 K (+8.89 %) |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Buy | M | 41.95 | 2,792 | 117,124 | 120,269 | 117.5 K to 120.3 K (+2.38 %) |
May 01 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 52.75 | 539 | 28,432 | 117,477 | 118 K to 117.5 K (-0.46 %) |
Mar 06 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.08 | 1,805 | 95,809 | 118,016 | 119.8 K to 118 K (-1.51 %) |
Mar 06 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.07 | 700 | 37,149 | 119,821 | 120.5 K to 119.8 K (-0.58 %) |
Mar 06 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.06 | 500 | 26,530 | 120,521 | 121 K to 120.5 K (-0.41 %) |
Mar 06 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.05 | 900 | 47,745 | 121,021 | 121.9 K to 121 K (-0.74 %) |
Mar 06 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.04 | 5,307 | 281,483 | 121,921 | 127.2 K to 121.9 K (-4.17 %) |
Mar 06 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 52.92 | 200 | 10,583 | 127,228 | 127.4 K to 127.2 K (-0.16 %) |
Mar 06 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 52.91 | 300 | 15,873 | 127,428 | 127.7 K to 127.4 K (-0.23 %) |
Mar 06 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 52.90 | 384 | 20,314 | 127,728 | 128.1 K to 127.7 K (-0.30 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.25 | 1,000 | 53,250 | 128,112 | 129.1 K to 128.1 K (-0.77 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.24 | 1,200 | 63,888 | 129,112 | 130.3 K to 129.1 K (-0.92 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.23 | 2,000 | 106,460 | 130,312 | 132.3 K to 130.3 K (-1.51 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.22 | 1,500 | 79,830 | 132,312 | 133.8 K to 132.3 K (-1.12 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.21 | 700 | 37,247 | 133,812 | 134.5 K to 133.8 K (-0.52 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.20 | 3,800 | 202,160 | 134,512 | 138.3 K to 134.5 K (-2.75 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 53.19 | 4,438 | 236,057 | 138,312 | 142.8 K to 138.3 K (-3.11 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 54.22 | 2,683 | 145,472 | 142,750 | 145.4 K to 142.8 K (-1.84 %) |
Feb 27 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | A | 54.54 | 10,856 | 592,086 | 10,856 | |
Feb 27 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | M | 42.50 | 12,768 | 542,612 | 0 | |
Feb 27 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 54.54 | 10,856 | 592,086 | 145,433 | 156.3 K to 145.4 K (-6.95 %) |
Feb 27 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Buy | M | 42.50 | 12,768 | 542,612 | 156,289 | 143.5 K to 156.3 K (+8.90 %) |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Option Exercise | A | 55.56 | 127,500 | 7,083,900 | 127,500 | |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 56.08 | 600 | 33,650 | 143,521 | 144.1 K to 143.5 K (-0.42 %) |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Sell | S | 56.08 | 284 | 15,927 | 144,121 | 144.4 K to 144.1 K (-0.20 %) |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 55.55 | 684 | 37,996 | 144,405 | 145.1 K to 144.4 K (-0.47 %) |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | Tyree James L | Executive Vice Pres ... | Payment of Exercise | F | 55.55 | 3,019 | 167,705 | 145,089 | 148.1 K to 145.1 K (-2.04 %) |